Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? von White, Francis J., Bednarz, Lisa M., Wachtel, Stephen R., Hjorth, Stephan, Brooderson, Richard J.

Volltext

Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study von Ip, Andrew, Berry, Donald A, Hansen, Eric, Goy, Andre H, Pecora, Andrew L, Sinclaire, Brittany A, Bednarz, Urszula, Marafelias, Michael, Berry, Scott M, Berry, Nicholas S, Mathura, Shivam, Sawczuk, Ihor S, Biran, Noa, Go, Ronaldo C, Sperber, Steven, Piwoz, Julia A, Balani, Bindu, Cicogna, Cristina, Sebti, Rani, Zuckerman, Jerry, Rose, Keith M, Tank, Lisa, Jacobs, Laurie G, Korcak, Jason, Timmapuri, Sarah L, Underwood, Joseph P, Sugalski, Gregory, Barsky, Carol, Varga, Daniel W, Asif, Arif, Landolfi, Joseph C, Goldberg, Stuart L

Volltext

Infant formula supplemented with milk fat globule membrane compared with standard infant formula for the cognitive development of healthy term-born formula-fed infants: protocol fo... von Gould, Jacqueline F, Gibson, Robert A, Yelland, Lisa N, Colombo, John, McPhee, Andrew J, Gallier, Sophie, Roberts, Rachel M, Shaddy, D. Jill, Bednarz, Jana, Makrides, Maria

Volltext

Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III von Kaufmann, Petra, Thompson, John L.P., Levy, Gilberto, Buchsbaum, Richard, Shefner, Jeremy, Krivickas, Lisa S., Katz, Jonathan, Rollins, Yvonne, Barohn, Richard J., Jackson, Carlayne E., Tiryaki, Ezgi, Lomen-Hoerth, Catherine, Armon, Carmel, Tandan, Rup, Rudnicki, Stacy A., Rezania, Kourosh, Sufit, Robert, Pestronk, Alan, Novella, Steven P., Heiman-Patterson, Terry, Kasarskis, Edward J., Pioro, Erik P., Montes, Jacqueline, Arbing, Rachel, Vecchio, Darleen, Barsdorf, Alexandra, Mitsumoto, Hiroshi, Levin, Bruce

Volltext

A68930: a potent agonist selective for the dopamine D1 receptor von DeNinno, M P, Schoenleber, R, MacKenzie, R, Britton, D R, Asin, K E, Briggs, C, Trugman, J M, Ackerman, M, Artman, L, Bednarz, L

Volltext

Tetrapeptide CCK-A Agonists: Effect of Backbone N-Methylations on in vitro and in vivo CCK Activity von Holladay, Mark W, Kopecka, Hana, Miller, Thomas R, Bednarz, Lisa, Nikkel, A. L, Bianchi, Bruce R, Witte, David G, Shiosaki, Kazumi, Lin, Chun Wel

Volltext

Synthesis and biological activity of CCK heptapeptide analogs. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity... von Holladay, Mark W, Bennett, Michael J, Tufano, Michael D, Lin, C. W, Asin, Karen E, Witte, David G, Miller, Thomas R, Bianchi, Bruce R, Nikkel, A. L

Volltext

Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus von Elliott, Richard L, Kopecka, Hana, Bennett, Michael J, Shue, Youe Kong, Craig, Richard, Lin, Chun Wel, Bianchi, Bruce R, Miller, Thomas R, Witte, David G

Volltext

A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptor von Kerkman, Daniel J., Ackerman, Martha, Artman, Linda D., MacKenzie, Robert G., Johnson, Marty C., Bednarz, Lisa, Montana, William, Asin, Karen E., Stampfli, Herman, Kebabian, John W.

Volltext

CCK-A-Selective Tetrapeptides Containing Lys(N.epsilon.)-Amide Residues: Favorable in vivo and in vitro Effects of N-Methylation at the Aspartyl Residue von Bennett, Michael J, Nikkel, A. L, Bianchi, Bruce R, Miller, Thomas R, Bednarz, Lisa, Witte, David G, Stashko, Michael, Wang, Song Shung, Gore, Paul A

Volltext

A68930: a potent agonist selective for the dopamine D 1 receptor von DeNinno, Michael P., Schoenleber, Robert, MacKenzie, Robert, Britton, Donald R., Asin, Karen E., Briggs, Clark, Trugman, Joel M., Ackerman, Martha, Artman, Linda, Bednarz, Lisa, Bhatt, Ramesh, Curzon, Peter, Gomez, Edwin, Chae Hee Kang, Stittsworth, James, Kebabian, John W.

Volltext